日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Longitudinal pharmacogenomic analysis of refractory lung cancer to identify therapeutic candidates for epidermal growth factor receptor-tyrosine kinase inhibitor resistance subclones.

对难治性肺癌进行纵向药物基因组学分析，以确定表皮生长因子受体酪氨酸激酶抑制剂耐药亚克隆的治疗候选药物

期刊:Experimental and Molecular Medicine
影响因子:12.9
doi:10.1038/s12276-025-01493-2
Yu Namhee, Hwang Mihwa, Ahn Beung Chul, Lee Youngjoo, Hong Sehwa, Sim Hanna, Song Bo Ram, Kim Sunshin, Park Charny, Han Ji-Youn
肿瘤
肺癌
肿瘤免疫
发表日期：2025
文献求助 收藏

VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

VEGF信号复杂性导致EGFR酪氨酸激酶抑制剂耐药的非小细胞肺癌对阿特珠单抗、贝伐珠单抗、卡铂和紫杉醇产生耐药性

期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70335
Hong, Sehwa; Yu, Namhee; Cho, Ju Young; Lee, Geon Kook; Ahn, Beung-Chul; Lee, Youngjoo; Sim, Hanna; Song, Bo Ram; Hwang, Mihwa; Kim, Sunshin; Kim, Jung-Hyun; Park, Charny; Han, Ji-Youn
肺癌
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
细胞生物学
VEGF
发表日期：2025
文献求助 收藏

Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy

患者来源肺癌细胞的药物反应可预测靶向治疗的临床结果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16040778
Kim, Sunshin; Lee, Youngjoo; Song, Bo Ram; Sim, Hanna; Kang, Eun Hye; Hwang, Mihwa; Yu, Namhee; Hong, Sehwa; Park, Charny; Ahn, Beung-Chul; Lim, Eun Jin; Hwang, Kum Hui; Park, Seog-Yun; Choi, Jin-Ho; Lee, Geon Kook; Han, Ji-Youn
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer

利用患者来源的细胞进行药物基因组学评估，揭示晚期肺癌的潜在耐药机制和新型疗法

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-023-02606-3
Yu, Namhee; Hwang, Mihwa; Lee, Youngjoo; Song, Bo Ram; Kang, Eun Hye; Sim, Hanna; Ahn, Beung-Chul; Hwang, Kum Hui; Kim, Jihyun; Hong, Sehwa; Kim, Sunshin; Park, Charny; Han, Ji-Youn
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report

MET扩增型非小细胞肺癌患者MYC扩增导致对卡马替尼产生原发性耐药：病例报告

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-22-176
Choi, Wonyoung; Jeong, Kyung-Chae; Park, Seog-Yun; Kim, Sunshin; Kang, Eun Hye; Hwang, Mihwa; Han, Ji-Youn
肺癌
肿瘤
肿瘤免疫
细胞生物学
MYC
MET
发表日期：2022
文献求助 收藏